World-renowned scientist, FDA consultant, and experienced manager to reinforce SLP board
Simulations Plus to Acquire DILIsym Services, Inc.
Accretive acquisition to expand Simulations Plus offerings by adding leading provider of drug-induced liver injury (DILI) software and consulting services
Simulations Plus Reports Second Quarter FY2017 Financial Results
Record second quarter as revenues grow 10.5%, 6MoFY17 net income up 13.6%
Simulations Plus Finalizes Distributor Agreement With Korean Company
Local sales channel should lead to further penetration of domestic Korean pharmaceutical market
Simulations Plus Releases GastroPlus™ Version 9.5
Significant update of top-rated program contains enhancements to several modules
Simulations Plus Reports First Quarter FY2017 Financial Results
Consolidated net earnings up 23.1% on 12% revenue increase
Simulations Plus Releases ADMET Predictor™ Version 8.1
Update streamlines key processes to efficiently handle large data sets
Simulations Plus Sets Date for 1st Quarter 2017 Earnings Release and Conference Call
Conference Call to be on Monday, January 9, 2017, at 4:15 PM ET
Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results
Full Fiscal Year Pharmaceutical Software and Services Up 9.1%;
Earnings per share $0.29, up 27.5% over prior year
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2016 Earnings Release and Conference Call
Conference Call to be on Friday, November 11, at 4:15 PM ET
Simulations Plus Joins European SimInhale Consortium
EU Framework Programme (Horizon 2020) for Acceleration of New Inhaled Medicines
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016
Company Reports Record Fourth-Quarter and Full-Year Revenues
Simulations Plus Releases PKPlus™ Version 1.0
Next-generation software for preclinical and clinical trial data analysis